Crinetics Pharmaceuticals, Inc. (CRNX)
54.74
-0.61
(-1.10%)
USD |
NASDAQ |
Jan 13, 09:52
Crinetics Pharmaceuticals Research and Development Expense (Quarterly): 89.45M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 173.65M |
| GT Biopharma, Inc. | 0.634M |
| Axsome Therapeutics, Inc. | 40.04M |
| Sutro Biopharma, Inc. | 39.85M |
| Gossamer Bio, Inc. | 45.54M |